BioPharma Credit PLC (MUN:B3P)
Germany flag Germany · Delayed Price · Currency is EUR
0.7950
0.00 (0.00%)
At close: Dec 1, 2025

BioPharma Credit Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
4.315.62135.05120.5394.71193.27
Cash & Short-Term Investments
4.315.62135.05120.5394.71193.27
Cash Growth
-88.41%-95.84%12.05%27.26%-51.00%-34.85%
Accounts Receivable
54.2131.7120.2319.739.590
Other Receivables
0.460.080.090.110.420.21
Receivables
54.6731.820.3219.8410.010.21
Total Current Assets
58.9837.42155.37140.37104.72193.48
Long-Term Investments
1,0991,1621,2011,2241,2661,195
Total Assets
1,1581,2001,3571,3641,3711,388
Accrued Expenses
7.4916.9415.8724.356.349.39
Other Current Liabilities
-0.95-1.95--
Total Current Liabilities
7.4917.8815.8726.36.349.39
Long-Term Unearned Revenue
-0.06-0.260.56-
Total Liabilities
7.4917.9415.8726.566.99.39
Common Stock
13.7413.7413.7413.7413.7413.74
Additional Paid-In Capital
607.13607.13607.13607.13607.13607.13
Retained Earnings
529.45560.81720716.59742.85758.05
Shareholders' Equity
1,1501,1821,3411,3371,3641,379
Total Liabilities & Equity
1,1581,2001,3571,3641,3711,388
Net Cash (Debt)
4.315.62135.05120.5394.71193.27
Net Cash Growth
-88.41%-95.84%12.05%27.26%-51.00%-34.85%
Net Cash Per Share
0.000.000.100.090.070.14
Filing Date Shares Outstanding
1,1291,1401,2541,3191,3741,374
Total Common Shares Outstanding
1,1291,1861,3031,3191,3741,374
Working Capital
51.4819.53139.5114.0698.38184.08
Book Value Per Share
1.021.001.031.010.991.00
Tangible Book Value
1,1501,1821,3411,3371,3641,379
Tangible Book Value Per Share
1.021.001.031.010.991.00
Source: S&P Global Market Intelligence. Standard template. Financial Sources.